CBIO
Crescent Biopharma, Inc.
Crescent Biopharma, Inc. (CBIO) is currently in a range/mixed trend, above the 200-day MA but below the 50-day MA. RSI is at 37.7, with 2/3 trend checks passing.
CBIO with MA50 and MA200
Key levels & signals
Crescent Biopharma, Inc. (CBIO) looks more range-bound than strongly trending, but there are still a few supportive signs on the chart. The latest available price is $15.67, and 2 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 14.0% and above the 200-day moving average by 7.0%.
CBIO currently has an RSI reading of 37.7, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.
This page is designed to help you quickly understand what the CBIO chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.
About Crescent Biopharma, Inc.
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
Learn the indicators behind this page
More stock opportunities
Common questions about CBIO
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.